Brasofensine sulfate

Drugs of the Future

Volumn 24, Issue 2, 1999, Pages 128-132

  Graul, A ^a   Castaner J ^a  

^a PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2 RECEPTOR ANTAGONIST; AMANTADINE; ANTIPARKINSON AGENT; APOMORPHINE; BENSERAZIDE PLUS LEVODOPA; BRASOFENSINE; BROMOCRIPTINE; CABERGOLINE; CARBIDOPA PLUS LEVODOPA; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; DELTA OPIATE RECEPTOR AGONIST; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE UPTAKE INHIBITOR; ENTACAPONE; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR; NEUROPROTECTIVE AGENT; NEUROTROPHIC FACTOR; NICOTINIC AGENT; PERGOLIDE MESILATE; PRAMIPEXOLE; SELEGILINE; SEROTONIN 2C ANTAGONIST; THREO 3,4 DIHYDROXYPHENYLSERINE; TOLCAPONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; CLINICAL TRIAL; DRUG ACTIVITY; DRUG EFFECT; DRUG INDICATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; NONHUMAN; PARKINSON DISEASE;

EID: 0344141314     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1999.024.02.474033     Document Type: Article

References (17)

1. Moldt, P., Wätjen, F., Scheel-Krüger, J. (NeuroSearch A/S). Tropane-2-aldoxine derivatives as neurotransmiter reuptake inhibitors. EP 756596, JP 97505607, US 5736556, WO 9528401.
2. 11C]NS 2214 (BMS-204756) - An inhibitor of the dopamine transporter. J Label Compd Radiopharm 1997, 39: 959-72.
3. 11C]cocaine metabolites contribute to PET images of the baboon brain. J Neurochem 1994, 62: 1154-62.
4. 11C] β-CIT, a cocaine analogue. Preparation, autoradiography and preliminary PET investigations. Nucl Med Biol 1993, 20: 249-55.
5. Brownell, A.L., Elmaleh, D.R., Meltzer, P.C., Shoup, T.M., Brownell, G.L., Fischman, A.J., Madras, B.K. Cocaine congeners as PET imaging probes for dopamine terminals. J Nucl Med 1996, 37: 1186-92.
6. 18F]-labelled cocaine analogues as potential dopamine transporter ligands for positron emission tomography. Nucl Med Biol 1996, 23: 141-6.
7. 11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporter. Nucl Med Biol 1996, 23: 377-84.
8. 11C]β-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: Preparation, autoradiography, metabolite studies, and positron emission tomography examinations. Nucl Med Biol 1995, 22: 905-13.
9. 18F]fluoromethyl-BTCP and evaluation as a potential PET radioligand for the dopamine transporter in baboons. Nucl Med Biol 1993, 20: 727-33.
10. Fowler, J.S., Volkow, N.D., Wolf, A.P. et al. Mapping cocaine binding sites in human and baboon brain in vivo. Synapse 1989, 4: 371-7.
11. 11C]WIN-35,428). J Label Compd Radiopharm 1993, 33: 147-52.
12. Loc'h, C., Muller, L., Ottaviani, M., Halldin, C., Farde, L., Maziere, B. Synthesis of 2β-carbomethoxy-3β-(4-[76Br]bromophenyl)tropane ([76Br]β-CBT), a PET tracer for in vivo imaging of the dopamine uptake sites. J Label Compd Radiopharm 1995, 36: 385-92.
13. 11C]β-CIT-FE, a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomography. Synapse 1996, 22: 386-90.
14. Brasofensine - Parkinson's disease. NeuroSearch A/S Web Site http://www.neuroserch.dk/projects/develop.htm, Dec 9, 1998.
15. Pearce, R.K.B., Banerji, T., Scheel-Krüger, J., Jenner, P. The dopamine reuptake blocker NS 2214 increases locomotor activity but does not produce dyskinesias in MPTP-treated common marmosets. Br J Pharmacol 1995, 116(Suppl.): Abst 304P.
16. Brasofensine development status. NeuroSearch A/S Company Communication Dec 9, 1998.
17. NeuroSearch A/S today announced agreement with Bristol-Myers Squibb on development of brasofensine for the treatment of Parkinson's disease in Japan. NeuroSearch A/S Press Release Feb 6, 1998.